首页 > 市场调查报告书 > 製药

生物製剂基因治疗学和RNAi

市场调查报告书

商品编码

1605885

病毒敏化剂市场，规模，占有率，趋势，产业分析报告:各用途，各终端用户，各地区 - 市场预测 2025年～2034年

Viral Sensitizers Market Size, Share, Trends, Industry Analysis Report: By Application, End Users, and Region - Market Forecast, 2025-2034

出版日期: 2024年11月01日 | 出版商:

Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

根据Polaris Market Research的最新研究，到2034年，病毒致敏剂的市场规模预计将达到79.508亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

病毒增敏剂市场是指透过使病毒更容易受到治疗来提高抗病毒治疗和疫苗有效性的化合物和药物市场。这些敏化剂可以帮助克服抗药性机制并改善治疗效果，特别是在治疗爱滋病毒、肝炎和癌症相关病毒等病毒感染方面。

由于肿瘤学和传染病治疗的需求不断增加，病毒敏化剂市场正在经历显着成长。主要驱动因素包括免疫疗法的进步、癌症发生率的增加以及对创新治疗方法的需求。病毒增敏剂的开发正在出现商机，这些增敏剂可以提高化疗和放疗等现有治疗方法的有效性。预计的趋势表明，人们越来越关注标靶病毒疗法和个人化医疗，这与更广泛地推动精准医疗保健是一致的。总体而言，生物技术公司和医疗保健提供者之间正在进行的研究和合作预计将扩大市场。

病毒敏化剂市场报告亮点

就特定应用分析而言，抗病毒药物开发领域在市场中占据主导地位，并且由于全球对新出现的病毒感染的担忧日益加剧，预计该领域将增长最快。

从最终用户来看，製药和生物技术公司受益于广泛的研发投资和合作伙伴关係，引领市场。由于病毒疗法研究和临床试验的资金增加，研究机构预计将迅速成长。

由于其先进的医疗基础设施和高昂的研发成本，北美占据了最大的市场占有率。由于医疗保健投资的增加和生物技术领域的扩张，亚太地区成为成长最快的地区。

病毒敏化剂市场的主要参与者包括吉利德科学公司、辉瑞公司、默克公司和强生公司。

主要调查结果
简介
- 病毒敏化剂市场评估:地区，2020～2034年
北美
- 北美:各用途，2020～2034年
- 北美:各终端用户，2020～2034年
- 美国
- 加拿大
欧洲
- 欧洲:各用途，2020～2034年
- 欧洲:各终端用户，2020～2034年
- 英国
- 法国
- 德国
- 义大利
- 西班牙
- 荷兰
- 俄罗斯
- 其他欧洲
亚太地区
- 亚太地区:各用途，2020～2034年
- 亚太地区:各终端用户，2020～2034年
- 中国
- 印度
- 马来西亚
- 日本
- 印尼
- 韩国
- 澳洲
- 其他亚太地区
中东·非洲
- 中东·非洲:各用途，2020～2034年
- 中东·非洲:各终端用户，2020～2034年
- 沙乌地阿拉伯
- 阿拉伯联合大公国
- 以色列
- 南非
- 其他中东和非洲
南美
- 南美:各用途，2020～2034年
- 南美:各终端用户，2020～2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美国家

第8章竞争情形

扩大和收购的分析
- 扩大
- 收购
联盟/合作/协定/公开

第9章企业简介

Gilead Sciences
Pfizer
Merck & Co.
Johnson & Johnson
AbbVie
Bristol-Myers Squibb
Roche
Moderna
AstraZeneca
Alnylam Pharmaceuticals
Iovance Biotherapeutics
Cellectis
Bluebird Bio
Regeneron Pharmaceuticals

简介目录图表

Product Code: PM5231

The viral sensitizers market size is expected to reach USD 7,950.80 million by 2034, according to a new study by Polaris Market Research. The report "Viral Sensitizers Market Size, Share, Trends, Industry Analysis Report: By Application (Antiviral Drug Development, Vaccine Development, and Oncolytic Viral Therapies), End Users, and By Region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The viral sensitizers market refers to the market for compounds or agents that enhance the efficacy of antiviral treatments or vaccines by making viruses more susceptible to the therapies. These sensitizers helps to overcome resistance mechanisms and improve therapeutic outcomes, particularly in treating viral infections like HIV, hepatitis, and cancer-related viruses.

The viral sensitizers market is witnessing significant growth due to rising demand in oncology and infectious disease treatment. Key drivers include advancements in immunotherapy, increasing cancer prevalence, and the need for innovative treatment approaches. Opportunities are emerging in the development of viral sensitizers that enhance the efficacy of existing therapies, such as chemotherapy and radiotherapy. Anticipated trends show a growing focus on targeted viral therapies and personalized medicine, aligning with the broader push for precision healthcare. Overall, the market is expected to expand, fueled by ongoing research and collaborations between biotech firms and healthcare providers.

Viral Sensitizers Market Report Highlights

By application analysis, the antiviral drug development segment dominates the market, and is also expected to witness the fastest growth due to increasing global concerns over emerging viral infections.

By end users analysis, pharmaceutical and biotechnology companies lead the market, benefiting from extensive R&D investments and partnerships. Research institutes are projected to grow rapidly due to increased funding for viral therapy research and clinical trials.

North America holds the largest market share, owing to advanced healthcare infrastructure and high R&D spending. Asia Pacific is the fastest-growing region, driven by rising healthcare investments and expanding biotechnology sectors.

Key players in the viral sensitizers market include Gilead Sciences, Pfizer, Merck & Co., and Johnson & Johnson.

Polaris market research has segmented the viral sensitizers market report based on application, end users, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

Antiviral Drug Development
Vaccine Development
Oncolytic Viral Therapies

By End Users Outlook (Revenue - USD Million, 2020-2034)

Pharmaceutical Companies
Biotechnology Companies
Research Institutes
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Viral Sensitizers Market Insights

4.1. Viral Sensitizers Market - Market Snapshot
4.2. Viral Sensitizers Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Integration of Combination Therapies
  - 4.2.1.2. Advancements in Precision Medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Limited Market Awareness
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Viral Sensitizers Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Viral Sensitizers Market, by Application

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
5.3. Antiviral Drug Development
- 5.3.1. Global Viral Sensitizers Market, by Antiviral Drug Development, by Region, 2020-2034 (USD Million)
5.4. Vaccine Development
- 5.4.1. Global Viral Sensitizers Market, by Vaccine Development, by Region, 2020-2034 (USD Million)
5.5. Oncolytic Viral Therapies
- 5.5.1. Global Viral Sensitizers Market, by Oncolytic Viral Therapies, by Region, 2020-2034 (USD Million)

6. Global Viral Sensitizers Market, by End User

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
6.3. Pharmaceutical Companies
- 6.3.1. Global Viral Sensitizers Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Million)
6.4. Biotechnology Companies
- 6.4.1. Global Viral Sensitizers Market, by Biotechnology Companies, by Region, 2020-2034 (USD Million)
6.5. Research Institutes
- 6.5.1. Global Viral Sensitizers Market, by Research Institutes, by Region, 2020-2034 (USD Million)
6.6. Others
- 6.6.1. Global Viral Sensitizers Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Viral Sensitizers Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Viral Sensitizers Market Assessment, By Geography, 2020-2034 (USD Million)
7.3. Viral Sensitizers Market - North America
- 7.3.1. North America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
- 7.3.2. North America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.3.3. Viral Sensitizers Market - U.S.
  - 7.3.3.1. U.S.: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.3.3.2. U.S.: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.3.4. Viral Sensitizers Market - Canada
  - 7.3.4.1. Canada: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.3.4.2. Canada: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
7.4. Viral Sensitizers Market - Europe
- 7.4.1. Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
- 7.4.2. Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.3. Viral Sensitizers Market - UK
  - 7.4.3.1. UK: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.3.2. UK: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.4. Viral Sensitizers Market - France
  - 7.4.4.1. France: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.4.2. France: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.5. Viral Sensitizers Market - Germany
  - 7.4.5.1. Germany: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.5.2. Germany: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.6. Viral Sensitizers Market - Italy
  - 7.4.6.1. Italy: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.6.2. Italy: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.7. Viral Sensitizers Market - Spain
  - 7.4.7.1. Spain: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.7.2. Spain: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.8. Viral Sensitizers Market - Netherlands
  - 7.4.8.1. Netherlands: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.8.2. Netherlands: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.9. Viral Sensitizers Market - Russia
  - 7.4.9.1. Russia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.9.2. Russia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.4.10. Viral Sensitizers Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.4.10.2. Rest of Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
7.5. Viral Sensitizers Market - Asia Pacific
- 7.5.1. Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.3. Viral Sensitizers Market - China
  - 7.5.3.1. China: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.3.2. China: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.4. Viral Sensitizers Market - India
  - 7.5.4.1. India: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.4.2. India: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.5. Viral Sensitizers Market - Malaysia
  - 7.5.5.1. Malaysia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.5.2. Malaysia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.6. Viral Sensitizers Market - Japan
  - 7.5.6.1. Japan: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.6.2. Japan: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.7. Viral Sensitizers Market - Indonesia
  - 7.5.7.1. Indonesia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.7.2. Indonesia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.8. Viral Sensitizers Market - South Korea
  - 7.5.8.1. South Korea: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.8.2. South Korea: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.9. Viral Sensitizers Market - Australia
  - 7.5.9.1. Australia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.9.2. Australia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.5.10. Viral Sensitizers Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.5.10.2. Rest of Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
7.6. Viral Sensitizers Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.6.3. Viral Sensitizers Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.6.3.2. Saudi Arabia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.6.4. Viral Sensitizers Market - UAE
  - 7.6.4.1. UAE: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.6.4.2. UAE: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.6.5. Viral Sensitizers Market - Israel
  - 7.6.5.1. Israel: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.6.5.2. Israel: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.6.6. Viral Sensitizers Market - South Africa
  - 7.6.6.1. South Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.6.6.2. South Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.6.7. Viral Sensitizers Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.6.7.2. Rest of Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
7.7. Viral Sensitizers Market - Latin America
- 7.7.1. Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
- 7.7.2. Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.7.3. Viral Sensitizers Market - Mexico
  - 7.7.3.1. Mexico: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.7.3.2. Mexico: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.7.4. Viral Sensitizers Market - Brazil
  - 7.7.4.1. Brazil: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.7.4.2. Brazil: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.7.5. Viral Sensitizers Market - Argentina
  - 7.7.5.1. Argentina: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.7.5.2. Argentina: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
- 7.7.6. Viral Sensitizers Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
  - 7.7.6.2. Rest of Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Gilead Sciences
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Pfizer
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Merck & Co.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Johnson & Johnson
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. AbbVie
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Bristol-Myers Squibb
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Roche
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Moderna
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. AstraZeneca
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Alnylam Pharmaceuticals
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Iovance Biotherapeutics
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Cellectis
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Bluebird Bio
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. Regeneron Pharmaceuticals
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development

简介目录图表

List of Tables:

Table 1 Global Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 2 Global Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 3 North America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 4 North America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 5 U.S.: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 6 U.S.: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 7 Canada: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 8 Canada: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 9 Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 10 Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 11 UK: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 12 UK: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 13 France: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 14 France: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 15 Germany: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 16 Germany: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 17 Italy: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 18 Italy: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 19 Spain: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 20 Spain: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 21 Netherlands: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 22 Netherlands: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 23 Russia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 24 Russia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 25 Rest of Europe: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 26 Rest of Europe: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 27 Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 28 Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 29 China: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 30 China: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 31 India: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 32 India: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 33 Malaysia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 34 Malaysia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 35 Japan: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 36 Japan: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 37 Indonesia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 38 Indonesia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 39 South Korea: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 40 South Korea: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 41 Australia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 42 Australia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 43 Rest of Asia Pacific: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 44 Rest of Asia Pacific: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 45 Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 46 Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 47 Saudi Arabia: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 48 Saudi Arabia: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 49 UAE: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 50 UAE: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 51 Israel: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 52 Israel: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 53 South Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 54 South Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 55 Rest of Middle East & Africa: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 56 Rest of Middle East & Africa: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 57 Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 58 Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 59 Mexico: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 60 Mexico: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 61 Brazil: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 62 Brazil: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 63 Argentina: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 64 Argentina: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
Table 65 Rest of Latin America: Viral Sensitizers Market, by Application, 2020-2034 (USD Million)
Table 66 Rest of Latin America: Viral Sensitizers Market, by End User, 2020-2034 (USD Million)
List of Figures:
Figure 1. Global Viral Sensitizers Market, 2020-2034 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Application
Figure 7. Global Viral Sensitizers Market, by Application, 2024 & 2034 (USD Million)
Figure 8. Market by End User
Figure 9. Global Viral Sensitizers Market, by End User, 2024 & 2034 (USD Million)

02-2729-4219

+886-2-2729-4219

License/价格

病毒敏化剂市场，规模，占有率，趋势，产业分析报告:各用途，各终端用户，各地区 - 市场预测 2025年～2034年